Navigation Links
Bad Air Day Alert: Outdoor Air Pollutants at High Level
Date:8/17/2009

ST. PAUL, Minn., Aug. 17 /PRNewswire/ -- Higher summertime levels of outdoor ground-level ozone, microscopic particle pollution like smoke and smog, as well as other air pollutants may cause anyone who is sensitive to these airborne contaminants to experience shortness of breath, wheezing and coughing, and may also trigger asthma attacks and cause lung irritation(1). According to AIRNow.gov(2), a government-developed index for reporting daily air quality, the Northeast and Mid-Atlantic regions of the United States, including but not limited to Massachusetts, Delaware, Maryland, New Jersey, New York, Pennsylvania and Connecticut, are presently experiencing a code orange(3) bad air day with the air quality index showing unhealthy levels of ozone.

"Persons who are particularly susceptible to these effects, such as children, the elderly and those with respiratory problems, need to be aware of outdoor levels of air pollution," said Dr. Neil Schachter, past president of the American Lung Association of the City of New York and author of Life and Breath. "Even those who are healthy should avoid long-term outdoor exposure on a bad air day."

But, we also need to pay attention to indoor air quality as well. Although there is the potential for outdoor particles to make their way inside the home, many other particles start in the home and stay there unless you have a way to reduce them, notes Steve Ramos, featured home inspector on HGTV's House Detective. According to the EPA, indoor levels of some pollutants may be two to five times higher than outdoor levels.

"If you're trying to avoid outdoor pollution by staying indoors, take the proper steps to help improve the air quality in your home," said Ramos. "Remember to follow the four C's -- Control, Change, Close and Clean -- to help reduce indoor air pollutants."

  • C
    '/>"/>

SOURCE 3M
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Podcast Alert: Measures For Asthma Success
2. Webcast Alert: Medial Saude S/A Announces Second Quarter 2009 Earnings Conference Call Webcast
3. Webcast Alert: HCA Healthcare Announces HCA 2Q09 Earnings Report
4. Consumer Alert: Minimally Invasive Cosmetic Procedures Should Not Be Taken Lightly
5. Bad Air Day Alert: Outdoor Air Pollutants at High Level
6. Webcast Alert: Heska Announces Second Quarter 2009 Earnings Conference Call Webcast
7. Webcast Alert: Isis Pharmaceuticals Second Quarter 2009 Financial Results Conference Call
8. Webcast Alert: Genomma Lab Internacional, S.A.B. de C.V. Announces Second Quarter 2009 Results Conference Call
9. Media Alert: Questions Remain in Michael Jackson Autopsy - College of American Pathologists Has Forensic Pathologist Available to Answer Reporter Questions
10. Media Alert: July 10, Run Miles for Special Smiles
11. Webcast Alert: Isis Pharmaceuticals To Provide General Corporate Update in Conjunction with 2009 Annual Meeting of Stockholders

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)...on Discusses Key Provisions of Legislation, Contin... ST. CHARLES, Ill., Nov. 21 /PRNewswire-USNewswire...ing the landmark Affordable Health Care for Americ...h reform legislation forward, Congress has taken d...re system. Today, AARP hosted an educational foru...
(Date:11/21/2009)... NH based medical credentialing software compan...o form a partnerhsip with Amerinet, Inc., the lead...p will help to transform quality care within the h...s) November 21, 2009 -- ISG Group, LLC, doing busi...eement with Amerinet Inc., a leading national heal...
(Date:11/21/2009)... HAPPYneuron,s most popular and addictive game,...od Touch. , Mountain View...st popular and addictive game, SplitWords, is now ...s is designed to help banish that ,tip of the tong...brain game challenges the brain by encouraging us...
(Date:11/21/2009)... New Haven Dental Group merges their practice w...CT. , (PRWEB) November 21... partners Dr. David Gibson, Dr. Dean Cloutier, Dr....merged their growing practice with that of esteeme...ckman decided he wanted to retire from dentistry i...
(Date:11/20/2009)...Neurologist Closer to Understanding Brain Wiring a...USNewswire/ -- Dr. Jeremy Schmahmann, Professor of...st at the Massachusetts General Hospital in Boston...ry,s research on the new field of study called "Co...on. ,, Dr. Schmahmann is an award-winning leade...
Breaking Medicine News(10 mins):Health News:AARP Hosts Rep. Bill Foster In Health Care Reform Forum 2Health News:IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 2Health News:HAPPYneuron releases iPhone Brain Game 2Health News:HAPPYneuron releases iPhone Brain Game 3Health News:New Haven Dental Group Expands Their Vision 2Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2
...vione,s Technology,Transfer Center (TTC) in New Je...nspection by FDA. The inspection was carried out ...t the US FDA Center for Drug Evaluation and Resear...ral positive,comments on our systems and indicated...
...,s most accurate simulation model for,predicting h...NCETON, N.J., Oct. 29 The Robert Wood,Johnson Fou...million grant,to Archimedes, Inc., developer of a ...ons and policy leaders to determine,reliably and q...
...dern Psychology and Explodes Myths of ,Why ...H, Fla., Oct. 29 Some children have a,genetic pre... to raise than,others. The notion of ,there are no...ears, classical and modern,psychology suggested th...
... tumor tissue, experts say , MONDAY, Oct. 29 (Heal... doesn,t harm the sexual function of prostate canc... Chase Cancer Center in Philadelphia tracked 155 m... the tumor. , "IMRT is revolutionizing how we trea...
...hytherapy) are just as effective at curing prostat...hey are in older men, according to a study present... the American Society for Therapeutic Radiology an...e seeds into the prostate in order to kill the can...
...sing a special type of drug called a pharmaceutica...TGF-beta pathway prevents a serious side effect of...nary fibrosis (scarring of the lungs), thereby ext...n Society for Therapeutic Radiology and Oncologys ...
Other Medicine News:Health News:FDA Inspects Hovione's Technology Transfer Center in New Jersey 2Health News:Robert Wood Johnson Foundation Announces $15.6 Million Grant to Apply Power of the Archimedes Model to Critical Health Care Decisions 2Health News:Robert Wood Johnson Foundation Announces $15.6 Million Grant to Apply Power of the Archimedes Model to Critical Health Care Decisions 3Health News:Robert Wood Johnson Foundation Announces $15.6 Million Grant to Apply Power of the Archimedes Model to Critical Health Care Decisions 4Health News:Bad Children Can Happen to Good Parents: A Survival Manual for Parents of Difficult Children by Norman E. Hoffman, Ph.D. 2Health News:Bad Children Can Happen to Good Parents: A Survival Manual for Parents of Difficult Children by Norman E. Hoffman, Ph.D. 3Health News:Prostate Cancer Radiotherapy Won't Affect Sexual Function 2Health News:Radiation seeds effectively cure prostate cancer in young men 2Health News:Preventing lung scarring may extend lives of lung cancer patients 2
(Date:11/20/2009)... , , NEW YORK, Nov. 20 /PRNewswire/ -...earch report is available in its catalogue. ,, ...ew ,, http://www.reportlinker.com/p0164242/M....html#utm_source=prnewswire&utm_medium=pr&... adhesives and sealants is gaining preeminence in ...
(Date:11/20/2009)... , , HOUSTON, Nov. 20 /PRNewswire-First...nnounced that Dan Moore, President and Chief Execu...icer, will present at the 21st Annual Piper Jaffra... December 2, 2009 at 12:00 PM EST. The conference...mal slides will be presented. Piper Jaffray will ...
(Date:11/20/2009)... , , MEMPHIS, Tenn., Nov. 20 /PRNewswire-...rthopaedics Division is pleased to announce the si...e United States Department of Defense that may lea...tended to revolutionize the treatment of the limbs..., Last year, the Defense Advanced Research Projec...
Breaking Medicine Technology:Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 2Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 3Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 4Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 5Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 6Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 4Women with cystic fibrosis can have safe and successful fertility treatment 50402 1Women with cystic fibrosis can have safe and successful fertility treatment 50402 2Women with cystic fibrosis can have safe and successful fertility treatment 50402 3The European Association for the Study of the Liver renews publishing partnership with Elsevier 50397 1Single thawed embryo transfer after PGD does not affect pregnancy rates 9062 1Single thawed embryo transfer after PGD does not affect pregnancy rates 9062 2Single thawed embryo transfer after PGD does not affect pregnancy rates 9062 3
... Takeda Pharmaceutical Company,Limited (Takeda) an...pment,Center, Inc. submitted a New Drug Applicatio...tration (FDA) for alogliptin (development code:,SY...(DPP-4) inhibitor under,investigation for the trea... Diego, Inc., alogliptin was designed to selective...
...therapy in development for menopausal symptoms, A...mpany,today announced positive results from a pivo...eat postmenopausal women with vulvovaginal atrophy...p line data show that the,multi-center, double-bli...of its co-primary endpoints. The study was conduct...
Other Medicine Technology:Takeda Submits New Drug Application for Alogliptin (SYR-322) in the U.S. 2Takeda Submits New Drug Application for Alogliptin (SYR-322) in the U.S. 3Takeda Submits New Drug Application for Alogliptin (SYR-322) in the U.S. 4QuatRx Pharmaceuticals Announces Positive Phase 3 Results for Study of Ophena(TM) (ospemifene) to Treat Postmenopausal Vaginal Syndrome 2QuatRx Pharmaceuticals Announces Positive Phase 3 Results for Study of Ophena(TM) (ospemifene) to Treat Postmenopausal Vaginal Syndrome 3
Whelan-Moss T-Tube
Silicone Flat Hubless Drains
Bard® Channel Drain
Spencer Modified Biliary Wire Guides
Medicine Products: